CreditSights offers a comprehensive suite of research solutions that are designed to be flexible enough to meet your unique investment needs.
Download our latest report, 5 Questions on ESG: Pharmaceuticals, to get ahead of the issues, events and trends affecting the Pharmaceuticals industry.
Executive Summary: In continuation of our series of ESG conversations with CreditSights analysts, we discuss the US pharmaceutical sector with senior analyst Eric Axon. Topics include pharma’s poor public perception, patent gaming issues, the impact of COVID-19 vaccine efforts, and disclosure quality.
